Copyright
©The Author(s) 2021.
World J Stem Cells. Sep 26, 2021; 13(9): 1248-1277
Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1248
Published online Sep 26, 2021. doi: 10.4252/wjsc.v13.i9.1248
Figure 1 The clinical trials utilizing adipose-derived stem cells.
The data were retrieved from clinical trials databases Clinicaltrials.gov and PUBMED. A: Distribution of adipose-derived stem cells (ADSCs) clinical trials’ start and end dates. Clinical trials on bone regeneration with both identified start and end date are represented in blue. All others are represented in orange; B: Distribution of ADSCs clinical trials’ status; C: Distribution of ADSCs clinical trials’ phase; D: Distribution of ADSCs clinical trials’ targeted condition.
- Citation: Le Q, Madhu V, Hart JM, Farber CR, Zunder ER, Dighe AS, Cui Q. Current evidence on potential of adipose derived stem cells to enhance bone regeneration and future projection. World J Stem Cells 2021; 13(9): 1248-1277
- URL: https://www.wjgnet.com/1948-0210/full/v13/i9/1248.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v13.i9.1248